Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Evogene Secures 180-Day Nasdaq Extension to Regain $1 Bid Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.417
Mkt Cap
$6.479M
52W Low
$0.352
52W High
$1.5
52W Position info
18% above low
Off High info
72% below high
Rel. Volume info
32× avg
Market data snapshot near publication time

EVGN sits 18% above its 52-week low of $0.352 on elevated volume (32× avg).

Summary

Nasdaq granted Evogene an additional 180 days, until March 29, 2027, to regain the $1.00 minimum bid price. The company may pursue a reverse share split to comply.


Key Events · Legal and Risk Events · EVGN

  • Nasdaq Extension Granted

    Nasdaq granted an additional 180-day period, through March 29, 2027, to regain the $1.00 minimum bid price compliance.

  • Reverse Split on the Table

    Evogene explicitly states it may pursue a reverse share split to regain compliance, a move that would reduce the share count but not change market value.

  • Delisting Risk Remains

    If compliance is not demonstrated by March 29, 2027, Nasdaq will provide written notification that the company's securities will be delisted.

  • Activist Proxy Fight Backdrop

    The extension comes amid an ongoing activist proxy fight and a highly dilutive ATM program, compounding governance and survival concerns.


Analysis · EVGN · Industrial Applications And Services

A second 180-day grace period from Nasdaq pushes Evogene's minimum bid price compliance deadline to March 29, 2027. With the stock trading at $0.4168—far below the $1.00 threshold—the company explicitly states it may pursue a reverse share split to cure the deficiency. This development unfolds amid an ongoing activist proxy fight and a highly dilutive ATM program, making the delisting risk and potential reverse split a critical governance and survival issue for shareholders.

How filings like this one have moved

In the 30 days to Oct 15, 2026, 37.1% of the 989 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.42 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $0.35 to $1.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.3771 info
Change: -$0.033 (-8%) info
Market Cap: $5.997M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.3771 info
Change: -$0.0136 (-3%) info
Market Cap: $5.997M info
EVGN
Sep 15, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5281
Real-time Price: $0.3771 info
Change: -$0.151 (-29%) info
Market Cap: $5.997M info
EVGN
Sep 11, 2026, 6:31 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.4728
Real-time Price: $0.3771 info
Change: -$0.0957 (-20%) info
Market Cap: $5.997M info
EVGN
Sep 04, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.569
Real-time Price: $0.3771 info
Change: -$0.1919 (-34%) info
Market Cap: $5.997M info